Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)

NCT01635777 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

PKDL

Interventions

DRUG: Miltefosine
DRUG: Miltefosine

Sponsor

AB Foundation

Collaborators

[object Object]